List of new purchasing methods for larotrectinib

Introduction: With the rapid development of medical technology, innovative treatments for rare cancer gene mutations continue to emerge, bringing new hope to patients. Larotinib Since its official launch in China in April 2022, it has provided an unprecedented treatment option for adult and pediatric patients with locally advanced or metastatic solid tumors with NTRK gene fusions.

LarotinibDomestic purchase method

Hospital pharmacy purchase: Patients can go to a large domestic hospital with oncology or related departments, consult a doctor and issue a prescription for , and then purchase it directly at the hospital pharmacy. This approach can ensure the formality of drug sources and the safety of drug use.

Buy at specific pharmacies: Some pharmacies specialize in selling high-priced anti-cancer drugs, including larotrectinib. Patients can use the Internet or consult professionals to find out whether there are such pharmacies in their local area, and go there with the doctor's prescription to purchase.

Cross-border medical cooperation: For drugs that are difficult to obtain or are expensive domestically, patients can also consider purchasing larotrectinib from formal foreign channels through cross-border medical cooperation. This requires patients to fully understand relevant laws and regulations and ensure the authenticity of the drugs.

Charitable Assistance Programs: Some charities or patient assistance programs may provide assistance with expensive drugs such as larotrectinib to patients in financial need. Patients can actively learn relevant information and apply for assistance to reduce their financial burden.

LarotinibPrecautions

Central nervous system effects: Patients treated with larotinib may experience central nervous system adverse reactions such as dizziness, cognitive impairment, mood disorders, and sleep disorders. Patients and caregivers need to be extremely vigilant about these risks and avoid driving or operating hazardous machinery when experiencing neurological symptoms. Once relevant symptoms occur, you should seek medical treatment promptly and adjust your medication regimen according to the doctor's recommendations.

Bone fracture risk: Larotrectinib may increase a patient's risk of fracture. Patients should regularly evaluate their physical condition and watch for signs or symptoms of fractures. If there are any abnormalities, you should inform your doctor promptly and receive evaluation and treatment.

Hepatotoxicity: In the early stages of treatment, patients should closely monitor liver function to ensure timely detection and treatment of possible hepatotoxic reactions. The doctor will adjust the monitoring frequency and medication plan according to the patient's specific situation.

Embryo-fetal toxicity: Larotrectinib has embryo-fetal toxicity and may cause potential harm to the fetus. Pregnant women should avoid using this drug and use effective contraception during treatment. Women who wish to have children should carefully consider pregnancy plans for a period of time after treatment has ended.